Sort
172,184 grants matching “inflammation”
Host and viral genomic determinants of HIV latent reservoir size and characteristics in individuals with substance use disorders
$903,625Robert F Siliciano · Johns Hopkins University · R61 · FY2020 · DA
Role of Oxidative Stress and Inflammation in HIV Cardiovascular Risk
$903,615Cecilia M Shikuma · University Of Hawaii At Manoa · R01 · FY2008 · HL
Measuring cellular senescence to predict and prevent peripheral neuropathy
$903,506Natalia Mitin · Sapere Bio, Inc. · R44 · FY2022 · AG
Respiratory Effects of Silver and Carbon Nanomaterials (RESAC)
$903,505Junfeng Zhang · University Of Southern California · U19 · FY2012 · ES
HIV Tropism, Persistence, Inflammation and Neurocognition in Therapy Initiation
$903,410Ronald I Swanstrom · Univ Of North Carolina Chapel Hill · P01 · FY2012 · MH
Systemic Bone Loss Following Fracture in Humans
$903,358Galateia J Kazakia · University Of California, San Francisco · R01 · FY2024 · AG
INHALED NO IN PREVENTION OF CHRONIC LUNG DISEASE
$903,335Childrens Hospital Of Philadelphia · U01 · FY2004 · HL
Parametric Response Mapping in COPD
$903,303Meilan K Han · University Of Michigan At Ann Arbor · R01 · FY2015 · HL
Steroids and Cross-linking for Ulcer Treatment (SCUT II)
$903,252Thomas M Lietman · University Of California, San Francisco · UG1 · FY2020 · EY
Developing chemoenzymatic strategies, enzymes, and kits for accessible and affordable gangliosides
$903,216Lim Andrew Lee · Integrated Micro-Chromatography Systems, Inc. · R44 · FY2021 · GM
Determining the role of sphingolipids in Mycobacterium tuberculosis infection
$903,202Fikadu G. Tafesse · Oregon Health & Science University · R01 · FY2020 · AI
Exploration of novel block-and-lock agents alone and in combination for HIV remission in humanized mice
$903,157Susana T Valente · University Of Florida · R01 · FY2023 · AI
Baltimore Oral Epidemiology, Disease Effects, and HIV Evaluation Study (BEEHIVE)
$903,089Mark D Macek · University Of Maryland Baltimore · R01 · FY2020 · DE
Preclinical Studies of Novel Anti-Diabetic Lipids
$903,077Barbara B Kahn · Beth Israel Deaconess Medical Center · R56 · FY2017 · DK
Modeling drugs of abuse-HIV interactions using iPSC-derived human cerebral organoids
$903,048Pietro P Sanna · Scripps Research Institute, The · R01 · FY2024 · DA
Modeling drugs of abuse-HIV interactions using iPSC-derived human cerebral organoids
$903,048Pietro P Sanna · Scripps Research Institute, The · R01 · FY2025 · DA
Implantable Microarray Probe for Real-Time Glutamate and GABA Detection
$902,911Nicolaie Andrei Moldovan · Alcorix · R42 · FY2024 · NS
CAREER: Intercellular regulation of protein oxidation during aging
$902,839Javier M Apfeld · Northeastern University · · FY2018 · BIO
Regulation of Intestinal Transport
$902,780Gail A. Hecht · University Of Illinois At Chicago · P01 · FY2009 · DK
Mitigation of neurological damage following seizures
$902,694Pamela J Lein · University Of California At Davis · U54 · FY2015 · NS
ALZHEIMERS RESEARCH PROJECT: Alzheimer's disease drug development
$902,370Nigel H. Greig · National Institute On Aging · ZIA · FY2024 · AG
Regulation of Intestinal Transport
$902,051Gail A. Hecht · University Of Illinois At Chicago · P01 · FY2008 · DK
Regulation of mucosal immune responses by helminth infections
$902,045P'ng Loke · National Institute Of Allergy And Infectious Diseases · ZIA · FY2021 · AI
Alternatively activated macrophages during type 2 immune responses
$902,045P'ng Loke · National Institute Of Allergy And Infectious Diseases · ZIA · FY2021 · AI
Building the Evidence Base for Adaptive Treatment Sequences in Clinical High Risk
$902,037Patrick McGorry · Orygen Youth Health Research Centre · U01 · FY2015 · MH